Xiaowu Sun

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Coronavirus Disease

Cross Sectional

Top Venues

Healthcare (Basel, Switzerland)

Circulation. Cardiovascular quality and outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Matthew R Reynolds, Amy B Stein, Xiaowu Sun, Evangelos Hytopoulos, Steven R Steinhubl, David Joel Cohen
Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circulation. Cardiovascular quality and outcomes (2023)
Manuela di Fusco, Joseph C Cappelleri, Laura Anatale-Tardiff, Henriette Coetzer, Alon Yehoshua, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Ashley S Cha-Silva, Santiago M C Lopez, Xiaowu Sun
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US. Healthcare (Basel, Switzerland) 11 (20) (2023)
Manuela di Fusco, Xiaowu Sun, Laura Anatale-Tardiff, Alon Yehoshua, Henriette Coetzer, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy. Vaccines 11 (11) (2023)